Lixte Biotechnology Holdings, INC. (LIXT) — DEF 14A Filings
All DEF 14A filings from Lixte Biotechnology Holdings, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Lixte Seeks Shareholder Approval for Expanded Stock Plan, Director Slate
— Oct 27, 2025 Risk: medium
Lixte Biotechnology Holdings, Inc. (LIXT) is holding its 2025 Annual Meeting of Stockholders on December 8, 2025, to address several key proposals. The company -
Lixte Biotechnology Holdings DEF 14A Filing
— Nov 5, 2024 Risk: low
LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a Definitive Proxy Statement (DEF 14A) on November 5, 2024. This filing is related to the company's annual meeting and
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX